Service & Software
Global AI Drug Design Market Research Report 2023
- Jan 18, 24
- ID: 2396
- Pages: 84
- Figures: 167
- Views: 19
AI drug design refers to the use of artificial intelligence and computational methods to discover, design, and develop new pharmaceutical drugs. By employing machine learning algorithms, AI Drug Design can analyze vast amounts of chemical and biological data, predict drug-target interactions, generate virtual compound libraries, and propose potential drug candidates. It aims to accelerate the drug discovery process, improve the success rate of candidate molecules, and facilitate the development of more effective and targeted medications.
According to HengCe’s new survey, global AI Drug Design market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
Key companies engaged in the AI Drug Design industry include Exscientia, PathAI, Tempus, Aria Pharmaceuticals, BenchSci, Antidote, AiCure, Atomwise and Envisagenics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of AI Drug Design were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole AI Drug Design market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI Drug Design market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Exscientia
PathAI
Tempus
Aria Pharmaceuticals
BenchSci
Antidote
AiCure
Atomwise
Envisagenics
Sherlock
Deep Genomics
Benevolent
Iktos
AlmirallShare
Segment by Type
Therapy Research
Design and Development
Others
Segment by Application
Cancer
Cardiovascular Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI Drug Design report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to HengCe’s new survey, global AI Drug Design market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
Key companies engaged in the AI Drug Design industry include Exscientia, PathAI, Tempus, Aria Pharmaceuticals, BenchSci, Antidote, AiCure, Atomwise and Envisagenics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of AI Drug Design were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole AI Drug Design market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global AI Drug Design market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Exscientia
PathAI
Tempus
Aria Pharmaceuticals
BenchSci
Antidote
AiCure
Atomwise
Envisagenics
Sherlock
Deep Genomics
Benevolent
Iktos
AlmirallShare
Segment by Type
Therapy Research
Design and Development
Others
Segment by Application
Cancer
Cardiovascular Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The AI Drug Design report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Design Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Therapy Research
1.2.3 Design and Development
1.2.4 Others
1.3 Market by Application
1.3.1 Global AI Drug Design Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Design Market Perspective (2018-2029)
2.2 AI Drug Design Growth Trends by Region
2.2.1 Global AI Drug Design Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 AI Drug Design Historic Market Size by Region (2018-2023)
2.2.3 AI Drug Design Forecasted Market Size by Region (2024-2029)
2.3 AI Drug Design Market Dynamics
2.3.1 AI Drug Design Industry Trends
2.3.2 AI Drug Design Market Drivers
2.3.3 AI Drug Design Market Challenges
2.3.4 AI Drug Design Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Drug Design Players by Revenue
3.1.1 Global Top AI Drug Design Players by Revenue (2018-2023)
3.1.2 Global AI Drug Design Revenue Market Share by Players (2018-2023)
3.2 Global AI Drug Design Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Drug Design Revenue
3.4 Global AI Drug Design Market Concentration Ratio
3.4.1 Global AI Drug Design Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Design Revenue in 2022
3.5 AI Drug Design Key Players Head office and Area Served
3.6 Key Players AI Drug Design Product Solution and Service
3.7 Date of Enter into AI Drug Design Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Design Breakdown Data by Type
4.1 Global AI Drug Design Historic Market Size by Type (2018-2023)
4.2 Global AI Drug Design Forecasted Market Size by Type (2024-2029)
5 AI Drug Design Breakdown Data by Application
5.1 Global AI Drug Design Historic Market Size by Application (2018-2023)
5.2 Global AI Drug Design Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America AI Drug Design Market Size (2018-2029)
6.2 North America AI Drug Design Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America AI Drug Design Market Size by Country (2018-2023)
6.4 North America AI Drug Design Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Drug Design Market Size (2018-2029)
7.2 Europe AI Drug Design Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe AI Drug Design Market Size by Country (2018-2023)
7.4 Europe AI Drug Design Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Drug Design Market Size (2018-2029)
8.2 Asia-Pacific AI Drug Design Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific AI Drug Design Market Size by Region (2018-2023)
8.4 Asia-Pacific AI Drug Design Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Drug Design Market Size (2018-2029)
9.2 Latin America AI Drug Design Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America AI Drug Design Market Size by Country (2018-2023)
9.4 Latin America AI Drug Design Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Drug Design Market Size (2018-2029)
10.2 Middle East & Africa AI Drug Design Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa AI Drug Design Market Size by Country (2018-2023)
10.4 Middle East & Africa AI Drug Design Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exscientia
11.1.1 Exscientia Company Detail
11.1.2 Exscientia Business Overview
11.1.3 Exscientia AI Drug Design Introduction
11.1.4 Exscientia Revenue in AI Drug Design Business (2018-2023)
11.1.5 Exscientia Recent Development
11.2 PathAI
11.2.1 PathAI Company Detail
11.2.2 PathAI Business Overview
11.2.3 PathAI AI Drug Design Introduction
11.2.4 PathAI Revenue in AI Drug Design Business (2018-2023)
11.2.5 PathAI Recent Development
11.3 Tempus
11.3.1 Tempus Company Detail
11.3.2 Tempus Business Overview
11.3.3 Tempus AI Drug Design Introduction
11.3.4 Tempus Revenue in AI Drug Design Business (2018-2023)
11.3.5 Tempus Recent Development
11.4 Aria Pharmaceuticals
11.4.1 Aria Pharmaceuticals Company Detail
11.4.2 Aria Pharmaceuticals Business Overview
11.4.3 Aria Pharmaceuticals AI Drug Design Introduction
11.4.4 Aria Pharmaceuticals Revenue in AI Drug Design Business (2018-2023)
11.4.5 Aria Pharmaceuticals Recent Development
11.5 BenchSci
11.5.1 BenchSci Company Detail
11.5.2 BenchSci Business Overview
11.5.3 BenchSci AI Drug Design Introduction
11.5.4 BenchSci Revenue in AI Drug Design Business (2018-2023)
11.5.5 BenchSci Recent Development
11.6 Antidote
11.6.1 Antidote Company Detail
11.6.2 Antidote Business Overview
11.6.3 Antidote AI Drug Design Introduction
11.6.4 Antidote Revenue in AI Drug Design Business (2018-2023)
11.6.5 Antidote Recent Development
11.7 AiCure
11.7.1 AiCure Company Detail
11.7.2 AiCure Business Overview
11.7.3 AiCure AI Drug Design Introduction
11.7.4 AiCure Revenue in AI Drug Design Business (2018-2023)
11.7.5 AiCure Recent Development
11.8 Atomwise
11.8.1 Atomwise Company Detail
11.8.2 Atomwise Business Overview
11.8.3 Atomwise AI Drug Design Introduction
11.8.4 Atomwise Revenue in AI Drug Design Business (2018-2023)
11.8.5 Atomwise Recent Development
11.9 Envisagenics
11.9.1 Envisagenics Company Detail
11.9.2 Envisagenics Business Overview
11.9.3 Envisagenics AI Drug Design Introduction
11.9.4 Envisagenics Revenue in AI Drug Design Business (2018-2023)
11.9.5 Envisagenics Recent Development
11.10 Sherlock
11.10.1 Sherlock Company Detail
11.10.2 Sherlock Business Overview
11.10.3 Sherlock AI Drug Design Introduction
11.10.4 Sherlock Revenue in AI Drug Design Business (2018-2023)
11.10.5 Sherlock Recent Development
11.11 Deep Genomics
11.11.1 Deep Genomics Company Detail
11.11.2 Deep Genomics Business Overview
11.11.3 Deep Genomics AI Drug Design Introduction
11.11.4 Deep Genomics Revenue in AI Drug Design Business (2018-2023)
11.11.5 Deep Genomics Recent Development
11.12 Benevolent
11.12.1 Benevolent Company Detail
11.12.2 Benevolent Business Overview
11.12.3 Benevolent AI Drug Design Introduction
11.12.4 Benevolent Revenue in AI Drug Design Business (2018-2023)
11.12.5 Benevolent Recent Development
11.13 Iktos
11.13.1 Iktos Company Detail
11.13.2 Iktos Business Overview
11.13.3 Iktos AI Drug Design Introduction
11.13.4 Iktos Revenue in AI Drug Design Business (2018-2023)
11.13.5 Iktos Recent Development
11.14 AlmirallShare
11.14.1 AlmirallShare Company Detail
11.14.2 AlmirallShare Business Overview
11.14.3 AlmirallShare AI Drug Design Introduction
11.14.4 AlmirallShare Revenue in AI Drug Design Business (2018-2023)
11.14.5 AlmirallShare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Design Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Therapy Research
1.2.3 Design and Development
1.2.4 Others
1.3 Market by Application
1.3.1 Global AI Drug Design Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Design Market Perspective (2018-2029)
2.2 AI Drug Design Growth Trends by Region
2.2.1 Global AI Drug Design Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 AI Drug Design Historic Market Size by Region (2018-2023)
2.2.3 AI Drug Design Forecasted Market Size by Region (2024-2029)
2.3 AI Drug Design Market Dynamics
2.3.1 AI Drug Design Industry Trends
2.3.2 AI Drug Design Market Drivers
2.3.3 AI Drug Design Market Challenges
2.3.4 AI Drug Design Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Drug Design Players by Revenue
3.1.1 Global Top AI Drug Design Players by Revenue (2018-2023)
3.1.2 Global AI Drug Design Revenue Market Share by Players (2018-2023)
3.2 Global AI Drug Design Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Drug Design Revenue
3.4 Global AI Drug Design Market Concentration Ratio
3.4.1 Global AI Drug Design Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Design Revenue in 2022
3.5 AI Drug Design Key Players Head office and Area Served
3.6 Key Players AI Drug Design Product Solution and Service
3.7 Date of Enter into AI Drug Design Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Design Breakdown Data by Type
4.1 Global AI Drug Design Historic Market Size by Type (2018-2023)
4.2 Global AI Drug Design Forecasted Market Size by Type (2024-2029)
5 AI Drug Design Breakdown Data by Application
5.1 Global AI Drug Design Historic Market Size by Application (2018-2023)
5.2 Global AI Drug Design Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America AI Drug Design Market Size (2018-2029)
6.2 North America AI Drug Design Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America AI Drug Design Market Size by Country (2018-2023)
6.4 North America AI Drug Design Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Drug Design Market Size (2018-2029)
7.2 Europe AI Drug Design Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe AI Drug Design Market Size by Country (2018-2023)
7.4 Europe AI Drug Design Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Drug Design Market Size (2018-2029)
8.2 Asia-Pacific AI Drug Design Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific AI Drug Design Market Size by Region (2018-2023)
8.4 Asia-Pacific AI Drug Design Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Drug Design Market Size (2018-2029)
9.2 Latin America AI Drug Design Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America AI Drug Design Market Size by Country (2018-2023)
9.4 Latin America AI Drug Design Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Drug Design Market Size (2018-2029)
10.2 Middle East & Africa AI Drug Design Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa AI Drug Design Market Size by Country (2018-2023)
10.4 Middle East & Africa AI Drug Design Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Exscientia
11.1.1 Exscientia Company Detail
11.1.2 Exscientia Business Overview
11.1.3 Exscientia AI Drug Design Introduction
11.1.4 Exscientia Revenue in AI Drug Design Business (2018-2023)
11.1.5 Exscientia Recent Development
11.2 PathAI
11.2.1 PathAI Company Detail
11.2.2 PathAI Business Overview
11.2.3 PathAI AI Drug Design Introduction
11.2.4 PathAI Revenue in AI Drug Design Business (2018-2023)
11.2.5 PathAI Recent Development
11.3 Tempus
11.3.1 Tempus Company Detail
11.3.2 Tempus Business Overview
11.3.3 Tempus AI Drug Design Introduction
11.3.4 Tempus Revenue in AI Drug Design Business (2018-2023)
11.3.5 Tempus Recent Development
11.4 Aria Pharmaceuticals
11.4.1 Aria Pharmaceuticals Company Detail
11.4.2 Aria Pharmaceuticals Business Overview
11.4.3 Aria Pharmaceuticals AI Drug Design Introduction
11.4.4 Aria Pharmaceuticals Revenue in AI Drug Design Business (2018-2023)
11.4.5 Aria Pharmaceuticals Recent Development
11.5 BenchSci
11.5.1 BenchSci Company Detail
11.5.2 BenchSci Business Overview
11.5.3 BenchSci AI Drug Design Introduction
11.5.4 BenchSci Revenue in AI Drug Design Business (2018-2023)
11.5.5 BenchSci Recent Development
11.6 Antidote
11.6.1 Antidote Company Detail
11.6.2 Antidote Business Overview
11.6.3 Antidote AI Drug Design Introduction
11.6.4 Antidote Revenue in AI Drug Design Business (2018-2023)
11.6.5 Antidote Recent Development
11.7 AiCure
11.7.1 AiCure Company Detail
11.7.2 AiCure Business Overview
11.7.3 AiCure AI Drug Design Introduction
11.7.4 AiCure Revenue in AI Drug Design Business (2018-2023)
11.7.5 AiCure Recent Development
11.8 Atomwise
11.8.1 Atomwise Company Detail
11.8.2 Atomwise Business Overview
11.8.3 Atomwise AI Drug Design Introduction
11.8.4 Atomwise Revenue in AI Drug Design Business (2018-2023)
11.8.5 Atomwise Recent Development
11.9 Envisagenics
11.9.1 Envisagenics Company Detail
11.9.2 Envisagenics Business Overview
11.9.3 Envisagenics AI Drug Design Introduction
11.9.4 Envisagenics Revenue in AI Drug Design Business (2018-2023)
11.9.5 Envisagenics Recent Development
11.10 Sherlock
11.10.1 Sherlock Company Detail
11.10.2 Sherlock Business Overview
11.10.3 Sherlock AI Drug Design Introduction
11.10.4 Sherlock Revenue in AI Drug Design Business (2018-2023)
11.10.5 Sherlock Recent Development
11.11 Deep Genomics
11.11.1 Deep Genomics Company Detail
11.11.2 Deep Genomics Business Overview
11.11.3 Deep Genomics AI Drug Design Introduction
11.11.4 Deep Genomics Revenue in AI Drug Design Business (2018-2023)
11.11.5 Deep Genomics Recent Development
11.12 Benevolent
11.12.1 Benevolent Company Detail
11.12.2 Benevolent Business Overview
11.12.3 Benevolent AI Drug Design Introduction
11.12.4 Benevolent Revenue in AI Drug Design Business (2018-2023)
11.12.5 Benevolent Recent Development
11.13 Iktos
11.13.1 Iktos Company Detail
11.13.2 Iktos Business Overview
11.13.3 Iktos AI Drug Design Introduction
11.13.4 Iktos Revenue in AI Drug Design Business (2018-2023)
11.13.5 Iktos Recent Development
11.14 AlmirallShare
11.14.1 AlmirallShare Company Detail
11.14.2 AlmirallShare Business Overview
11.14.3 AlmirallShare AI Drug Design Introduction
11.14.4 AlmirallShare Revenue in AI Drug Design Business (2018-2023)
11.14.5 AlmirallShare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global AI Drug Design Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Therapy Research
Table 3. Key Players of Design and Development
Table 4. Key Players of Others
Table 5. Global AI Drug Design Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global AI Drug Design Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global AI Drug Design Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global AI Drug Design Market Share by Region (2018-2023)
Table 9. Global AI Drug Design Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global AI Drug Design Market Share by Region (2024-2029)
Table 11. AI Drug Design Market Trends
Table 12. AI Drug Design Market Drivers
Table 13. AI Drug Design Market Challenges
Table 14. AI Drug Design Market Restraints
Table 15. Global AI Drug Design Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global AI Drug Design Market Share by Players (2018-2023)
Table 17. Global Top AI Drug Design Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Design as of 2022)
Table 18. Ranking of Global Top AI Drug Design Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by AI Drug Design Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players AI Drug Design Product Solution and Service
Table 22. Date of Enter into AI Drug Design Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global AI Drug Design Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global AI Drug Design Revenue Market Share by Type (2018-2023)
Table 26. Global AI Drug Design Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global AI Drug Design Revenue Market Share by Type (2024-2029)
Table 28. Global AI Drug Design Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global AI Drug Design Revenue Market Share by Application (2018-2023)
Table 30. Global AI Drug Design Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global AI Drug Design Revenue Market Share by Application (2024-2029)
Table 32. North America AI Drug Design Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America AI Drug Design Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America AI Drug Design Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe AI Drug Design Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe AI Drug Design Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe AI Drug Design Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific AI Drug Design Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific AI Drug Design Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific AI Drug Design Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America AI Drug Design Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America AI Drug Design Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America AI Drug Design Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa AI Drug Design Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa AI Drug Design Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa AI Drug Design Market Size by Country (2024-2029) & (US$ Million)
Table 47. Exscientia Company Detail
Table 48. Exscientia Business Overview
Table 49. Exscientia AI Drug Design Product
Table 50. Exscientia Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 51. Exscientia Recent Development
Table 52. PathAI Company Detail
Table 53. PathAI Business Overview
Table 54. PathAI AI Drug Design Product
Table 55. PathAI Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 56. PathAI Recent Development
Table 57. Tempus Company Detail
Table 58. Tempus Business Overview
Table 59. Tempus AI Drug Design Product
Table 60. Tempus Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 61. Tempus Recent Development
Table 62. Aria Pharmaceuticals Company Detail
Table 63. Aria Pharmaceuticals Business Overview
Table 64. Aria Pharmaceuticals AI Drug Design Product
Table 65. Aria Pharmaceuticals Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 66. Aria Pharmaceuticals Recent Development
Table 67. BenchSci Company Detail
Table 68. BenchSci Business Overview
Table 69. BenchSci AI Drug Design Product
Table 70. BenchSci Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 71. BenchSci Recent Development
Table 72. Antidote Company Detail
Table 73. Antidote Business Overview
Table 74. Antidote AI Drug Design Product
Table 75. Antidote Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 76. Antidote Recent Development
Table 77. AiCure Company Detail
Table 78. AiCure Business Overview
Table 79. AiCure AI Drug Design Product
Table 80. AiCure Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 81. AiCure Recent Development
Table 82. Atomwise Company Detail
Table 83. Atomwise Business Overview
Table 84. Atomwise AI Drug Design Product
Table 85. Atomwise Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 86. Atomwise Recent Development
Table 87. Envisagenics Company Detail
Table 88. Envisagenics Business Overview
Table 89. Envisagenics AI Drug Design Product
Table 90. Envisagenics Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 91. Envisagenics Recent Development
Table 92. Sherlock Company Detail
Table 93. Sherlock Business Overview
Table 94. Sherlock AI Drug Design Product
Table 95. Sherlock Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 96. Sherlock Recent Development
Table 97. Deep Genomics Company Detail
Table 98. Deep Genomics Business Overview
Table 99. Deep Genomics AI Drug Design Product
Table 100. Deep Genomics Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 101. Deep Genomics Recent Development
Table 102. Benevolent Company Detail
Table 103. Benevolent Business Overview
Table 104. Benevolent AI Drug Design Product
Table 105. Benevolent Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 106. Benevolent Recent Development
Table 107. Iktos Company Detail
Table 108. Iktos Business Overview
Table 109. Iktos AI Drug Design Product
Table 110. Iktos Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 111. Iktos Recent Development
Table 112. AlmirallShare Company Detail
Table 113. AlmirallShare Business Overview
Table 114. AlmirallShare AI Drug Design Product
Table 115. AlmirallShare Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 116. AlmirallShare Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AI Drug Design Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global AI Drug Design Market Share by Type: 2022 VS 2029
Figure 3. Therapy Research Features
Figure 4. Design and Development Features
Figure 5. Others Features
Figure 6. Global AI Drug Design Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global AI Drug Design Market Share by Application: 2022 VS 2029
Figure 8. Cancer Case Studies
Figure 9. Cardiovascular Disease Case Studies
Figure 10. Others Case Studies
Figure 11. AI Drug Design Report Years Considered
Figure 12. Global AI Drug Design Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global AI Drug Design Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global AI Drug Design Market Share by Region: 2022 VS 2029
Figure 15. Global AI Drug Design Market Share by Players in 2022
Figure 16. Global Top AI Drug Design Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Design as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by AI Drug Design Revenue in 2022
Figure 18. North America AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America AI Drug Design Market Share by Country (2018-2029)
Figure 20. United States AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe AI Drug Design Market Share by Country (2018-2029)
Figure 24. Germany AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific AI Drug Design Market Share by Region (2018-2029)
Figure 32. China AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America AI Drug Design Market Share by Country (2018-2029)
Figure 40. Mexico AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa AI Drug Design Market Share by Country (2018-2029)
Figure 44. Turkey AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Exscientia Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 47. PathAI Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 48. Tempus Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 49. Aria Pharmaceuticals Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 50. BenchSci Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 51. Antidote Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 52. AiCure Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 53. Atomwise Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 54. Envisagenics Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 55. Sherlock Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 56. Deep Genomics Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 57. Benevolent Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 58. Iktos Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 59. AlmirallShare Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global AI Drug Design Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Therapy Research
Table 3. Key Players of Design and Development
Table 4. Key Players of Others
Table 5. Global AI Drug Design Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global AI Drug Design Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global AI Drug Design Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global AI Drug Design Market Share by Region (2018-2023)
Table 9. Global AI Drug Design Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global AI Drug Design Market Share by Region (2024-2029)
Table 11. AI Drug Design Market Trends
Table 12. AI Drug Design Market Drivers
Table 13. AI Drug Design Market Challenges
Table 14. AI Drug Design Market Restraints
Table 15. Global AI Drug Design Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global AI Drug Design Market Share by Players (2018-2023)
Table 17. Global Top AI Drug Design Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Design as of 2022)
Table 18. Ranking of Global Top AI Drug Design Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by AI Drug Design Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players AI Drug Design Product Solution and Service
Table 22. Date of Enter into AI Drug Design Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global AI Drug Design Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global AI Drug Design Revenue Market Share by Type (2018-2023)
Table 26. Global AI Drug Design Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global AI Drug Design Revenue Market Share by Type (2024-2029)
Table 28. Global AI Drug Design Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global AI Drug Design Revenue Market Share by Application (2018-2023)
Table 30. Global AI Drug Design Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global AI Drug Design Revenue Market Share by Application (2024-2029)
Table 32. North America AI Drug Design Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America AI Drug Design Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America AI Drug Design Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe AI Drug Design Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe AI Drug Design Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe AI Drug Design Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific AI Drug Design Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific AI Drug Design Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific AI Drug Design Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America AI Drug Design Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America AI Drug Design Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America AI Drug Design Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa AI Drug Design Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa AI Drug Design Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa AI Drug Design Market Size by Country (2024-2029) & (US$ Million)
Table 47. Exscientia Company Detail
Table 48. Exscientia Business Overview
Table 49. Exscientia AI Drug Design Product
Table 50. Exscientia Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 51. Exscientia Recent Development
Table 52. PathAI Company Detail
Table 53. PathAI Business Overview
Table 54. PathAI AI Drug Design Product
Table 55. PathAI Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 56. PathAI Recent Development
Table 57. Tempus Company Detail
Table 58. Tempus Business Overview
Table 59. Tempus AI Drug Design Product
Table 60. Tempus Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 61. Tempus Recent Development
Table 62. Aria Pharmaceuticals Company Detail
Table 63. Aria Pharmaceuticals Business Overview
Table 64. Aria Pharmaceuticals AI Drug Design Product
Table 65. Aria Pharmaceuticals Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 66. Aria Pharmaceuticals Recent Development
Table 67. BenchSci Company Detail
Table 68. BenchSci Business Overview
Table 69. BenchSci AI Drug Design Product
Table 70. BenchSci Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 71. BenchSci Recent Development
Table 72. Antidote Company Detail
Table 73. Antidote Business Overview
Table 74. Antidote AI Drug Design Product
Table 75. Antidote Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 76. Antidote Recent Development
Table 77. AiCure Company Detail
Table 78. AiCure Business Overview
Table 79. AiCure AI Drug Design Product
Table 80. AiCure Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 81. AiCure Recent Development
Table 82. Atomwise Company Detail
Table 83. Atomwise Business Overview
Table 84. Atomwise AI Drug Design Product
Table 85. Atomwise Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 86. Atomwise Recent Development
Table 87. Envisagenics Company Detail
Table 88. Envisagenics Business Overview
Table 89. Envisagenics AI Drug Design Product
Table 90. Envisagenics Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 91. Envisagenics Recent Development
Table 92. Sherlock Company Detail
Table 93. Sherlock Business Overview
Table 94. Sherlock AI Drug Design Product
Table 95. Sherlock Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 96. Sherlock Recent Development
Table 97. Deep Genomics Company Detail
Table 98. Deep Genomics Business Overview
Table 99. Deep Genomics AI Drug Design Product
Table 100. Deep Genomics Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 101. Deep Genomics Recent Development
Table 102. Benevolent Company Detail
Table 103. Benevolent Business Overview
Table 104. Benevolent AI Drug Design Product
Table 105. Benevolent Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 106. Benevolent Recent Development
Table 107. Iktos Company Detail
Table 108. Iktos Business Overview
Table 109. Iktos AI Drug Design Product
Table 110. Iktos Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 111. Iktos Recent Development
Table 112. AlmirallShare Company Detail
Table 113. AlmirallShare Business Overview
Table 114. AlmirallShare AI Drug Design Product
Table 115. AlmirallShare Revenue in AI Drug Design Business (2018-2023) & (US$ Million)
Table 116. AlmirallShare Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AI Drug Design Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global AI Drug Design Market Share by Type: 2022 VS 2029
Figure 3. Therapy Research Features
Figure 4. Design and Development Features
Figure 5. Others Features
Figure 6. Global AI Drug Design Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global AI Drug Design Market Share by Application: 2022 VS 2029
Figure 8. Cancer Case Studies
Figure 9. Cardiovascular Disease Case Studies
Figure 10. Others Case Studies
Figure 11. AI Drug Design Report Years Considered
Figure 12. Global AI Drug Design Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global AI Drug Design Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global AI Drug Design Market Share by Region: 2022 VS 2029
Figure 15. Global AI Drug Design Market Share by Players in 2022
Figure 16. Global Top AI Drug Design Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Design as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by AI Drug Design Revenue in 2022
Figure 18. North America AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America AI Drug Design Market Share by Country (2018-2029)
Figure 20. United States AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe AI Drug Design Market Share by Country (2018-2029)
Figure 24. Germany AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific AI Drug Design Market Share by Region (2018-2029)
Figure 32. China AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America AI Drug Design Market Share by Country (2018-2029)
Figure 40. Mexico AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa AI Drug Design Market Share by Country (2018-2029)
Figure 44. Turkey AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia AI Drug Design Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Exscientia Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 47. PathAI Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 48. Tempus Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 49. Aria Pharmaceuticals Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 50. BenchSci Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 51. Antidote Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 52. AiCure Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 53. Atomwise Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 54. Envisagenics Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 55. Sherlock Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 56. Deep Genomics Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 57. Benevolent Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 58. Iktos Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 59. AlmirallShare Revenue Growth Rate in AI Drug Design Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232